NCT02383888View on ClinicalTrials.gov

Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy
Interventions
DRUG

BI 425809

DRUG

BI 425809

DRUG

Placebo

DRUG

BI 425809

Trial Locations (1)

Unknown

1346.4.82001 Boehringer Ingelheim Investigational Site, Busan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY